{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T22:29:01Z","timestamp":1785536941691,"version":"3.56.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100011096","name":"Jazz Pharmaceuticals","doi-asserted-by":"publisher","award":["NCT02362529"],"award-info":[{"award-number":["NCT02362529"]}],"id":[{"id":"10.13039\/100011096","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000196","name":"Canada Foundation for Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA04066"],"award-info":[{"award-number":["DA04066"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","award":["GSD-157948"],"award-info":[{"award-number":["GSD-157948"]}],"id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","award":["MOP-136955"],"award-info":[{"award-number":["MOP-136955"]}],"id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005155","name":"Azrieli Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005155","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000874","name":"Brain and Behavior Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000874","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["biologicalpsychiatryjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.biopsych.2020.03.007","type":"journal-article","created":{"date-parts":[[2020,3,28]],"date-time":"2020-03-28T23:04:38Z","timestamp":1585436678000},"page":"649-656","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Translocator Protein Distribution Volume Predicts Reduction of Symptoms During Open-Label Trial of Celecoxib in Major Depressive Disorder"],"prefix":"10.1016","volume":"88","author":[{"given":"Sophia","family":"Attwells","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Setiawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo M.","family":"Rusjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste","family":"Hutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorsa","family":"Rafiei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Varughese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Kish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2087-5125","authenticated-orcid":false,"given":"Neil","family":"Vasdev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Houle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey H.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2020.03.007_bib1","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/jnen\/63.9.901","article-title":"Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases","volume":"63","author":"Minghetti","year":"2004","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"key":"10.1016\/j.biopsych.2020.03.007_bib2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrn2038","article-title":"Microglia-mediated neurotoxicity: Uncovering the molecular mechanisms","volume":"8","author":"Block","year":"2007","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.biopsych.2020.03.007_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14728222.2019.1554056","article-title":"The COX-2\/prostanoid signaling cascades in seizure disorders","volume":"23","author":"Rojas","year":"2019","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.biopsych.2020.03.007_bib4","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1365-2990.2008.01006.x","article-title":"Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain","volume":"35","author":"Cosenza-Nashat","year":"2009","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.biopsych.2020.03.007_bib5","doi-asserted-by":"crossref","first-page":"E785","DOI":"10.3390\/ijms18040785","article-title":"Translocator protein-18 kDa (TSPO) positron emission tomography (PET) imaging and its clinical impact in neurodegenerative diseases","volume":"18","author":"Dupont","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.biopsych.2020.03.007_bib6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/A:1018567510105","article-title":"PK (\u201cperipheral benzodiazepine\u201d)\u2014binding sites in the CNS indicate early and discrete brain lesions: Microautoradiographic detection of [3H]PK11195 binding to activated microglia","volume":"26","author":"Banati","year":"1997","journal-title":"J\u00a0Neurocytol"},{"key":"10.1016\/j.biopsych.2020.03.007_bib7","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/jcbfm.2009.205","article-title":"Evaluation of the PBR\/TSPO radioligand [18F]DPA-714 in a rat model of focal cerebral ischemia","volume":"30","author":"Martin","year":"2010","journal-title":"J\u00a0Cereb Blood Flow Metab"},{"key":"10.1016\/j.biopsych.2020.03.007_bib8","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1080\/13550280701549417","article-title":"Human immunodeficiency virus infection inhibits granulocyte-macrophage colony-stimulating factor-induced microglial proliferation","volume":"13","author":"Cosenza-Nashat","year":"2007","journal-title":"J\u00a0Neurovirol"},{"key":"10.1016\/j.biopsych.2020.03.007_bib9","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/NEN.0b013e318188b204","article-title":"The positron emission tomography ligand DAA1106 binds with high affinity to activated microglia in human neurological disorders","volume":"67","author":"Venneti","year":"2008","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"key":"10.1016\/j.biopsych.2020.03.007_bib10","doi-asserted-by":"crossref","first-page":"E2707","DOI":"10.3390\/ijms19092707","article-title":"Cellular sources and regional variations in the expression of the neuroinflammatory marker translocator protein (TSPO) in the normal brain","volume":"19","author":"Betlazar","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"suppl 1","key":"10.1016\/j.biopsych.2020.03.007_bib11","first-page":"81P","article-title":"Comparison of [11C]PBR28 and [18F]FEPPA as CNS peripheral benzodiazepine receptor PET ligands in the pig","volume":"49","author":"Bennacef","year":"2008","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.biopsych.2020.03.007_bib12","doi-asserted-by":"crossref","first-page":"T94","DOI":"10.1016\/j.neuroimage.2008.04.063","article-title":"In-vivo imaging of microglial activation using a novel peripheral benzodiazepine receptor ligand, 18F-FEPPA and animal PET following 6-OHDA injury of the rat striatum; A comparison with 11C-PK11195","volume":"41","author":"Kudo","year":"2008","journal-title":"NeuroImage"},{"key":"10.1016\/j.biopsych.2020.03.007_bib13","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.nucmedbio.2007.12.009","article-title":"Radiosynthesis and initial evaluation of [18F]-FEPPA for PET imaging of peripheral benzodiazepine receptors","volume":"35","author":"Wilson","year":"2008","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.biopsych.2020.03.007_bib14","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1038\/jcbfm.2011.55","article-title":"Quantitation of translocator protein binding in human brain with the novel radioligand [18F]-FEPPA and positron emission tomography","volume":"31","author":"Rusjan","year":"2011","journal-title":"J\u00a0Cereb Blood Flow Metab"},{"key":"10.1016\/j.biopsych.2020.03.007_bib15","series-title":"The World Health Report 2001: Mental Health: New Understanding, New Hope","year":"2001"},{"key":"10.1016\/j.biopsych.2020.03.007_bib16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR\u2217D: Implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2020.03.007_bib17","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1001\/jamapsychiatry.2014.2427","article-title":"Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes","volume":"72","author":"Setiawan","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.biopsych.2020.03.007_bib18","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S2215-0366(18)30048-8","article-title":"Association of translocator protein total distribution volume with duration of untreated major depressive disorder: A cross-sectional study","volume":"5","author":"Setiawan","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.biopsych.2020.03.007_bib19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13550-018-0401-9","article-title":"PET radioligand binding to translocator protein (TSPO) is increased in unmedicated depressed subjects","volume":"8","author":"Richards","year":"2018","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.biopsych.2020.03.007_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pnpbp.2017.12.011","article-title":"Translocator protein (18kDa TSPO) binding, a marker of microglia, is reduced in major depression during cognitive-behavioral therapy","volume":"83","author":"Li","year":"2018","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2020.03.007_bib21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.biopsych.2017.08.005","article-title":"Elevated translocator protein in anterior cingulate in major depression and a role for inflammation in suicidal thinking: A positron emission tomography study","volume":"83","author":"Holmes","year":"2018","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2020.03.007_bib22","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/s41467-019-09562-7","article-title":"Lower synaptic density is associated with depression severity and network alterations","volume":"10","author":"Holmes","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.biopsych.2020.03.007_bib23","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/nn1944","article-title":"Targeting abnormal neural circuits in mood and anxiety disorders: From the laboratory to the clinic","volume":"10","author":"Ressler","year":"2007","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.biopsych.2020.03.007_bib24","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A\u00a0rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.biopsych.2020.03.007_bib25","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1073\/pnas.98.3.1294","article-title":"Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice","volume":"98","author":"Iadecola","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2020.03.007_bib26","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/s41598-017-00609-7","article-title":"Cyclooxygenase-2 signalling pathway in the cortex is involved in the pathophysiological mechanisms in the rat model of depression","volume":"7","author":"Chen","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.biopsych.2020.03.007_bib27","first-page":"891","article-title":"A\u00a0randomized, double-blind, placebo-controlled trial of celecoxib augmentation of sertraline in treatment of drug-naive depressed women: A pilot study","volume":"14","author":"Majd","year":"2015","journal-title":"Iran J Pharmaceut Res"},{"key":"10.1016\/j.biopsych.2020.03.007_bib28","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jad.2012.03.033","article-title":"Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: Randomized double-blind placebo-controlled study","volume":"141","author":"Abbasi","year":"2012","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.biopsych.2020.03.007_bib29","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/da.20589","article-title":"Clinical trial of adjunctive celecoxib treatment in patients with major depression: A double blind and placebo controlled trial","volume":"26","author":"Akhondzadeh","year":"2009","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.biopsych.2020.03.007_bib30","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/sj.mp.4001805","article-title":"The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: Results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine","volume":"11","author":"Muller","year":"2006","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2020.03.007_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/jcbfm.2011.147","article-title":"An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28","volume":"32","author":"Owen","year":"2012","journal-title":"J\u00a0Cereb Bood Flow Metabolism"},{"key":"10.1016\/j.biopsych.2020.03.007_bib32","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/jcbfm.2012.46","article-title":"Translocator protein (18 kDa) polymorphism (rs6971) explains in-vivo brain binding affinity of the PET radioligand [18F]-FEPPA","volume":"32","author":"Mizrahi","year":"2012","journal-title":"J\u00a0Cereb Blood Flow Metab"},{"key":"10.1016\/j.biopsych.2020.03.007_bib33","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2020.03.007_bib34","doi-asserted-by":"crossref","first-page":"225","DOI":"10.4088\/JCP.v63n0309","article-title":"Duloxetine in the treatment of major depressive disorder: A double-blind clinical trial","volume":"63","author":"Goldstein","year":"2002","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.biopsych.2020.03.007_bib35","doi-asserted-by":"crossref","first-page":"308","DOI":"10.4088\/JCP.v63n0407","article-title":"Duloxetine, 60 mg once daily, for major depressive disorder: A randomized double-blind placebo-controlled trial","volume":"63","author":"Detke","year":"2002","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.biopsych.2020.03.007_bib36","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1001\/jamapsychiatry.2019.0044","article-title":"Monoamine oxidase B total distribution volume in the prefrontal cortex of major depressive disorder: An [11C]SL25.1188 positron emission tomography study","volume":"76","author":"Moriguchi","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.biopsych.2020.03.007_bib37","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1176\/appi.ajp.2017.16070759","article-title":"Role of complex epigenetic switching in tumor necrosis factor-alpha upregulation in the prefrontal cortex of suicide subjects","volume":"175","author":"Wang","year":"2018","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2020.03.007_bib38","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1503\/jpn.170192","article-title":"Abnormal protein and mRNA expression of inflammatory cytokines in the prefrontal cortex of depressed individuals who died by suicide","volume":"43","author":"Pandey","year":"2018","journal-title":"J\u00a0Psychiatry Neurosci"},{"key":"10.1016\/j.biopsych.2020.03.007_bib39","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pnpbp.2017.11.017","article-title":"Altered neuro-inflammatory gene expression in hippocampus in major depressive disorder","volume":"82","author":"Mahajan","year":"2018","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2020.03.007_bib40","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.2967\/jnumed.118.211144","article-title":"Evaluation of two potent and selective PET radioligands to image COX-1 and COX-2 in rhesus monkeys","volume":"59","author":"Kim","year":"2018","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.biopsych.2020.03.007_bib41","doi-asserted-by":"crossref","first-page":"E1929","DOI":"10.3390\/molecules23081929","article-title":"In\u00a0Vivo Brain Imaging, Biodistribution, and Radiation Dosimetry Estimation of [11C]Celecoxib, a COX-2 PET Ligand, in Nonhuman Primates","volume":"23","author":"Kumar","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.biopsych.2020.03.007_bib42","doi-asserted-by":"crossref","first-page":"pyv036","DOI":"10.1093\/ijnp\/pyv036","article-title":"Large variation in brain exposure of reference CNS drugs: A PET study in nonhuman primates","volume":"18","author":"Schou","year":"2015","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2020.03.007_bib43","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00000542-200502000-00026","article-title":"Central nervous system concentrations of cyclooxygenase-2 inhibitors in humans","volume":"102","author":"Dembo","year":"2005","journal-title":"Anesthesiology"},{"key":"10.1016\/j.biopsych.2020.03.007_bib44","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.biopsych.2015.10.018","article-title":"Intravenous esketamine in adult treatment-resistant depression: A double-blind, double-randomization, placebo-controlled study","volume":"80","author":"Singh","year":"2016","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2020.03.007_bib45","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S2215-0366(17)30371-1","article-title":"Subcallosal cingulate deep brain stimulation for treatment-resistant depression: A multisite, randomised, sham-controlled trial","volume":"11","author":"Holtzheimer","year":"2017","journal-title":"Lancet Psychiatry"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322320313263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322320313263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:03:43Z","timestamp":1762099423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322320313263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0006322320313263"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2020.03.007","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Translocator Protein Distribution Volume Predicts Reduction of Symptoms During Open-Label Trial of Celecoxib in Major Depressive Disorder","name":"articletitle","label":"Article Title"},{"value":"Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopsych.2020.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}